dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Grau Exposito, Judit |
dc.contributor.author | Luque Ballesteros, Laura |
dc.contributor.author | Navarro Mercadé, Jordi |
dc.contributor.author | Curran Fàbregas, Adria |
dc.contributor.author | Burgos Cibrian, Joaquin |
dc.contributor.author | Ribera Pascuet, Esteve |
dc.contributor.author | Torrella Domingo, Ariadna |
dc.contributor.author | Planas Ribas, Bibiana |
dc.contributor.author | Badía Royes, Rosa María |
dc.contributor.author | Martin Castillo, Mario |
dc.contributor.author | Fernandez Sojo, Jesus |
dc.contributor.author | Genesca Ferrer, Meritxell |
dc.contributor.author | Falcó Ferrer, Vicenç |
dc.contributor.author | Buzón Gómez, María José |
dc.date.accessioned | 2020-03-02T13:43:35Z |
dc.date.available | 2020-03-02T13:43:35Z |
dc.date.issued | 2019-08-19 |
dc.identifier.citation | Grau-Expósito J, Luque-Ballesteros L, Navarro J, Curran A, Burgos J, Ribera E, et al. Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations. PLoS Pathog. 2019 Aug 19;15(8):e1007991. |
dc.identifier.issn | 1553-7366 |
dc.identifier.uri | https://hdl.handle.net/11351/4693 |
dc.description | Cèl·lula T CD4 +; VIH-1; Reservori latent |
dc.description.sponsorship | This study was supported by the American National Institutes of Health (grant R21AI118411 to MJB), the Spanish Secretariat of Science and Innovation and FEDER funds (grant SAF2015-67334-R [MINECO/FEDER]), a unrestricted research grant from Bristol-Myers Squibb S.A.U (PfC-2015 AI424-564) to MJB, the Spanish "Ministerio de Economia y Competitividad, Instituto de Salud Carlos III"(ISCIII, PI17/01470) to M.G, a research grant from Gilead Sciences (GLD17-00204) to M. B, GeSIDA and the Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA" (RD16/0025/0007) to ER. The Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179) to MJB. The "Pla estrategic de recerca i innovacioen salut" (PERIS), from the Catalan Government to MG. |
dc.language.iso | eng |
dc.publisher | Public Library of Science |
dc.relation.ispartofseries | PLoS Pathogens;15(8) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Antiretrovirals |
dc.subject | Virus - Reproducció |
dc.subject | Cèl·lules T |
dc.subject.mesh | Anti-HIV Agents |
dc.subject.mesh | Virus Latency |
dc.subject.mesh | CD4-Positive T-Lymphocytes |
dc.title | Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1371/journal.ppat.1007991 |
dc.subject.decs | fármacos anti-VIH |
dc.subject.decs | latencia viral |
dc.subject.decs | linfocitos T CD4-positivos |
dc.relation.publishversion | https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1007991 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Grau-Expósito J, Luque-Ballesteros L, Navarro J, Curran A, Burgos J, Ribera E, Torrella A, Planas B, Badía R, Martin-Castillo M, Genescà M, Falcó V, Buzon MJ] Servei de Malalties Infeccioses, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR). Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Fernández-Sojo J] Banc de Sang i Teixits, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain |
dc.identifier.pmid | 31425551 |
dc.identifier.wos | 000488322100036 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |